FIELD: pharmaceutics; medicine.
SUBSTANCE: invention relates to the use of a composition for treating and/or preventing a disease or syndrome associated with a viral infection in a subject in need thereof, where viral infection causes acute inflammation, directly or indirectly inducing disease or syndrome, and where the viral infection is a coronavirus infection MERS-CoV, wherein the composition comprises a therapeutically effective amount of alpha-1-antitrypsin (AAT) protein.
EFFECT: inhibition of penetration of MERS-CoV into cells.
8 cl, 26 dwg, 11 tbl, 25 ex
| Title |
Year |
Author |
Number |
| ALPHA-1-ANTITRYPSIN (AAT) IN TREATMENT AND (OR) PREVENTION OF NEUROLOGICAL DISORDERS |
2022 |
|
RU2840475C2 |
| SOLUBLE ACE2, FUSED PROTEIN THEREOF AND METHODS OF USING THEM |
2021 |
- Li, Venkhuej
- Tsi, Yunkhe
- Chen, Tszyankhe
- Suj, Tszyankhua
- Lyu, Khuan
- Mao, Fenfen
- Lyu, Simin
|
RU2837537C1 |
| BISPECIFIC MONOCLONAL ANTIBODY AGAINST SARS-COV-2 |
2022 |
- Malogolovkin Aleksandr Sergeevich
- Katorkin Sergej Aleksandrovich
- Bondar Nikolaj Igorevich
|
RU2791749C1 |
| METHODS FOR TREATING INFECTIOUS DISEASES CAUSED BY CORONAVIRUS |
2021 |
|
RU2772701C1 |
| TREATMENT OF CORONAVIRUS INFECTION |
2021 |
- Ben-Asher, Dror
- Fathi, Reza
|
RU2837859C1 |
| THERAPEUTIC AGENT AGAINST CORONAVIRUS INCLUDING AN ELAEOCARPUS SYLVESTRIS EXTRACT |
2021 |
- Kang, Se Chan
- Jeong, Yong Joon
- Jeon, Hye Lin
- Her, Yang Mi
|
RU2780346C1 |
| 5-[4-(1,3-BENZOTHIAZOL-2-YL)PHENYL]-10,15,20-TRIS(1-METHYLPYRIDINIUM-3-YL)PORPHYRIN TRIIOODIDE, SHOWING THE BINDING PROPERTY OF THE SARS-CoV-2 VIRUS SPIKE PROTEIN |
2021 |
- Syrbu Sergej Aleksandrovich
- Kiselev Aleksej Nikolaevich
- Gubarev Yurij Aleksandrovich
- Lebedeva Natalya Shamilevna
- Semejkin Aleksandr Stanislavovich
- Kojfman Oskar Iosifovich
|
RU2773397C1 |
| METHOD FOR DETERMINING THE ACTIVITY OF NEUTRALISING ANTIBODIES AGAINST SARS-CoV-2 IN THE SERUM OR PLASMA OF PEOPLE WITH PAST CASES OF COVID-19 OR VACCINATED WITH PREVENTIVE VACCINES AGAINST THE NOVEL CORONAVIRUS INFECTION COVID-19 USING A SET OF ENZYME IMMUNOASSAY REAGENTS CONTAINING A RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF SURFACE GLYCOPROTEIN S OF CORONAVIRUS SARS-CoV-2 AND RECOMBINANT HUMAN RECEPTOR ACE2 |
2021 |
- Kostin Nikita Nikolaevich
- Bobik Tatyana Vladimirovna
- Skryabin Georgij Andreevich
- Simonova Mariya Aleksandrovna
- Balmasova Irina Petrovna
- Abrikosova Viktoriya Aleksandrovna
- Mokrushina Yuliana Anatolevna
- Smirnov Ivan Vitalevich
- Aleshenko Natalya Leonidovna
- Nikitin Aleksej Eduardovich
- Chekhonin Vladimir Pavlovich
- Gabibov Aleksandr Gabibovich
|
RU2784655C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING POLYNUCLEOTIDES, AND USE THEREOF FOR PREVENTING OR TREATING COVID-19 |
2021 |
- Zhang, Yi
- Liu, Yuan
- Zhang, Nan
|
RU2824489C1 |
| METHOD FOR THE TREATMENT OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 |
2021 |
- Ivanov Evgenii Ignatevich
- Monakhov Maksim Viacheslavovich
|
RU2775966C1 |
